Direktorat Registrasi ObatValid

RIZONAX

Claim this product
BPOM Number
DKL0433510817A1
Approved
7 August 2026
Expiry
5 November 2030
Form
TABLET SALUT SELAPUT

About This Registration

RIZONAX is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL0433510817A1. Its current registration status is Valid, with the licence valid until 5 November 2030. The product is registered to NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA. BPOM first approved this registration in August 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 8 August 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
DUS, 3 STRIP @ 10 TABLET SALUT SELAPUT
Department
Direktorat Registrasi Obat
Data Last Updated
8 August 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

EPERISONE HYDROCHLORIDE

Market Intelligence

Owner Portfolio
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA holds 559 BPOM registrations
Manufacturer Scale
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA produces 559 registered products
Update Status
Recently updated (1 days ago)

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1